Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles

Immunology

Volumn 87, Issue 2, 1996, Pages 171-178

  Layton, G T ^a,c   Harris, S J ^a   Myhan, J ^a   West, D ^a   Gotch, F ^a   Hill Perkins, M ^a   Cole, J S ^a   Meyers, N ^a   Woodrow, S ^a   French, T J ^a   Adams, S E ^a   Kingsman, A J ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; SYNTHETIC PEPTIDE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYBRID; IMMUNITY; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENDAI VIRUS; T LYMPHOCYTE; VIRUS INFECTION;

EID: 9044243027     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.464539.x     Document Type: Article

References (41)

1. YAP K.L., ADA G.L. & MCKENZIE I.F.C. (1978) Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273, 238.
2. KLAVINSKIS L.S., WHITTON J.L. & OLDSTONE M.B.A. (1989) Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal infection. J Virol 63, 4311.
3. MELEIF C.J.M. & KAST W.M. (1991) T cell immunotherapy of cancer. Res Immunol 142, 425.
4. WRAITH D.C. & ASKONAS B.A. (1985) Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation. J Gen Virol 66, 1327.
5. STAERZ U.D., KARASUGAMA H. & GARNER A.M. (1990) Cytotoxic T lymphocytes against soluble protein. Nature 329, 449.
6. TAKAHASHI H., TAKESHITA T., MOREIN B., PUTNEY S., GERMAIN R.N. & BERZOFSKY J.A. (1990) Induction of CD8+ cytotoxic T lymphocytes by immunisation with purified HIV-1 envelope protein in ISCOMs. Nature 344, 873.
7. WU, J.-Y., GARDNER B.H., MURPHY C.I. et al. (1992) Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol 148, 1519.
8. REDDY R., ZHOU F., NAIR S., HUANG L. & ROUSE B.T. (1992) In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J Immunol 148, 1585.
9. RAYCHAUDHURI S., TONKS M., CARBONE F., RYSKAMP T., MORROW W.J.W. & HANNA N. (1992) Induction of antigen-specific class 1-restricted cytotoxic T cells by soluble proteins in vivo. Proc Natl Acad Sci USA 89, 8308.
10. DILLON S.B., DEMUTH S.G., SCHNEIDER M.A. et al. (1992) Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine 10, 309.
11. DERES K., SCHILD H., WEISMULLER K.H., JUNG G. & RAMMENSEE H.G. (1989) In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342, 561.
12. CARBONE F.R. & BEVAN M.J. (1989) Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunisation. J Exp Med 169, 603.
13. GAO, X.-M. ZHENO B., LIEW F.Y., BRETT S. & TITE J. (1991) Priming of influenza virus-specific cytotoxic T lymphocytes in vivo by short synthetic peptides. J Immunol 147, 3268.
14. SCHULZ M., ZINKERNAGEL R.M. & HENGARTNER H. (1991) Peptide-induced antiviral protection by cytotoxic T cells. Proc Natl Acad Sci USA 88, 991.
15. KAST W.M., ROUX L., CURREN J. et al. (1991) Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci USA 88, 2283.
16. ZHOU F., ROUSE B.T. & HUANG L. (1992) Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J Immunol 149, 1599.
17. DONELLY J.J., ULMER J.B., HAWE L.A. et al (1993) Targeted delivery of peptides to class I major histocompatability molecules by a modified Pseudomonas exotoxin. Proc Natl Acad Sci USA 90, 3530.
18. KOVACSOVICS-BANKOWSKI M., CLARK K., BENACERRAF B. & ROCK K.L. (1993) Efficient major histocompatability complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 90, 4942.
19. + cytotoxic T cells. J Exp Med 172, 1083.
20. GRIFFITHS J.C., HARRIS S.J., LAYTON G.T. et al. (1993) Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J Virol 61, 3191.
21. KINGSMAN S.M. & KINGSMAN A.J. (1988) Polyvalent recombinant antigens: a new vaccine strategy. Vaccine 1988, 6, 304.
22. ADAMS S.E., DAWSON K.M., GULL K., KINGSMAN S.M. & KINGSMAN A.J. (1987) The expression of hybrid HIV:Ty virus-like particles in yeast. Nature 329, 68.
23. GRIFFITHS J.C., BURRIE E.L., HOLDSWORTH L.N. et al. (1991) Induction of high-titer neutralising antibodies, using hybrid human immunodeficiency virus V3-Ty virus-like particles in a clinically relevant adjuvant. J Virol 65, 450.
24. HARRIS S.J., GEARING A.J.H., LAYTON G.T., ADAMS S.E., KINGSMAN S.M. & KINGSMAN A.J. (1993) Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunisation with V3:Ty virus-like particles. Immunology 77, 315.
25. LAYTON G.T., HARRIS S.J., GEARING A.J.H. et al. (1993) HIV-specific cytotoxic T lymphocytes are primed in vivo using hybrid HIV-1 V3:Ty-virus-like particles. In: Vaccines 93 (eds F. Brown, R.M. Chanock, R.A. Lerner & H. Ginsburg), p. 85. Cold Spring Harbor Laboratory Press, Plainview, NY.
26. LAYTON G.T., HARRIS S.J., GEARING A.J.H. et al. (1993) Induction of HIV-specific cytotoxic T lymphocytes in rim with hybrid HIV-1 V3:Ty-virus-like particles. J Immunol 151, 1097.
27. HARRIS S.J., GEARING A.J.H., WOODROW S.A., ADAMS S.E., KINGSMAN A.J. & LAYTON G.T. (1994) Effects of adjuvants on the induction of V3-specific CTL responses by immunisation of mice with V3:Ty VLP. In: Vaccines 94 (eds F. Brown, R.M. Chanock, R.A. Lerner & H. Ginsburg), p. 1. Cold Spring Harbor Laboratory Press, Plainview, NY.
28. + cytotoxic T lymphocyte responses in vivo. J Immunol 152, 1110.
29. ADAMS S.E., RICHARDSON S.M.H., KINGSMAN S.M. & KINGSMAN A.J. (1991) Expression vectors for the construction of hybrid Ty-VLPs. In: Methods in Molecular Biology, Vol. 8 (ed. M. Collins), p. 265. The Humana Press, Clifton, NJ.
30. BURNS N.R., GILMOUR J.E.M., KINGSMAN S.M., KINGSMAN A.J. & ADAMS S. E. (1991) Production and purification of hybrid Ty-VLP. In: Methods in Molecular Biology, Vol. 8. (ed. M. Collins), p. 277. The Humana Press, Clifton NJ.
31. OLDSTONE M. (1991) Molecular anatomy of viral persistence. J Virol 65, 6381.
32. ELLIOT T., SMITH M., DRISCOLL P. & MCMICHAEL A. (1993) Peptide selection by class I molecules of the major histocompatability complex. Curr Biol 3, 854.
33. BOOMER H.C., PEMBERTON R.M., ROTHBARD J.B. & ASKONAS B.A. (1988) Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein. Cell 52, 253.
34. TAKAHASHI H., COHEN J., HOSMALIN A. et al. (1988) An immunodominant epitope of human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatability complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci USA 85, 3105.
35. LASARTE, J.-J., SAROBE P., GULLON A., PRIETO J. & BORRAS-CUESTA F. (1992) Induction of cytotoxic T lymphocytes in mice against the principal neutralising domain of HIV-1 by immunisation with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell Immunol 141, 211.
36. d restricted antigenic peptides share a simple binding motif. J Exp Med 174, 603.
37. TOWNSEND A., BASTIN J., GOULD K. et al. (1988) Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 168, 1211.
38. EISENLOHR L.C., YEWDELL J.W. & BENNINK J.R. (1992) Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J Exp Med 175, 481.
39. WHITTON J.L., SHENG N., OLDSTONE M.A. & MCKEE T.A. (1993) A 'string of beads' vaccine confers protection from lethal-dose virus challenge. J Virol 67, 348.
40. HALE P.M., CEASE K.B., HOUGHTEN R.A. et al. (1989) T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatability complex restriction. Int Immunol 1, 409.
41. PERKINS D.L., BERRIZ G., KAMRADT T., SMITH J.A. & GEFTER M.L. (1991) Immunodominance: intramolecular competition between T cell epitopes. J Immunol 146, 2137.